24-hour glucose profiles during continuous or oscillatory insulin infusion. Demonstration of the functional significance of ultradian insulin oscillations.
Sturis, J.; Scheen, André; Leproult, R.et al.
1995 • In Journal of Clinical Investigation, 95 (4), p. 1464-71
[en] Under basal and stimulated conditions, normal insulin secretion oscillates with periods in the ultradian 100-150-min range. To test the hypothesis that oscillatory insulin delivery is more efficient in reducing blood glucose levels than continuous administration, nine normal young men were each studied on two occasions during a 28-h period including a period of polygraphically recorded sleep. Endogenous insulin secretion was suppressed by somatostatin, a constant intravenous glucose infusion was administered, and exogenous insulin was infused either at a constant rate or in a sinusoidal pattern with a period of 120 min. The mean glucose level over the 28-h period was 0.72 +/- 0.31 mmol/liter lower when insulin was infused in an oscillatory pattern than when the rate of infusion was constant (P < 0.05). The greater hypoglycemic effect of oscillatory versus constant infusion was particularly marked during the daytime, with the difference averaging 1.04 +/- 0.38 mmol/liter (P < 0.03). Serum insulin levels tended to be lower during oscillatory than constant infusion, although the same amount of exogenous insulin was administered under both conditions. Ultradian insulin oscillations appear to promote more efficient glucose utilization.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Sturis, J.
Scheen, André ; Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale
Leproult, R.
Polonsky, K. S.
van Cauter, E.
Language :
English
Title :
24-hour glucose profiles during continuous or oscillatory insulin infusion. Demonstration of the functional significance of ultradian insulin oscillations.
Publication date :
1995
Journal title :
Journal of Clinical Investigation
ISSN :
0021-9738
eISSN :
1558-8238
Publisher :
American Society for Clinical Investigation, Ann Arbor, United States - Michigan
Belchetz, P. E., T. M. Plant, Y. Nakai, E. J. Keogh, and E. Knobil. 1978. Hypophysial responses to continuous and intermittent delivery of hypothalamic gonadotropin releasing hormone. Science (Wash. DC). 202:631-633.
Hastings, M. H. 1991. Neuroendocrine rhythms. Pharmacol. & Ther. 50:35-71.
Sturis, J., K. S. Polonsky, E. T. Shapiro, J. D. Blackman, N. M. O'Meara, and E. Van Cauter. 1992. Abnormalities in the ultradian oscillations of insulin secretion and glucose levels in type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 35:681-689.
Sturis, J., N. M. O'Meara, E. T. Shapiro, J. D. Blackman, H. Tillil, K. S. Polonsky, and E. Van Cauter. 1993. Differential effects of glucose stimulation upon rapid pulses and ultradian oscillations of insulin secretion. J. Clin. Endocrinol. & Metab. 76:895-901.
Ookhtens, M., D. J. Marsh, S. W. Smith, R. N. Bergman, and F. E. Yates. 1974. Fluctuations of plasma glucose and insulin in conscious dogs receiving glucose infusions. Am. J. Physiol. 226:910-919.
Bowden, C. R., R. N. Bergman, and D. J. Marsh. 1980. Cause of glucose oscillations during glucose infusion: periodic variation in glucose uptake. Am. J. Physiol. 238:E395-E407.
Shapiro, E. T., H. Tillil, K. S. Polonsky, V. S. Fang, A. H. Rubenstein, and E. Van Cauter. 1988. Oscillations in insulin secretion during constant glucose infusion in normal man: relationship to changes in plasma glucose. J. Clin. Endocrinol. & Metab. 67:307-314.
Van Cauter, E., D. Désir, C. Decoster, F. Féry, and E. O. Balasse. 1989. Nocturnal decrease in glucose tolerance during constant glucose infusion. J. Clin. Endocrinol. & Metab. 69:604-611.
Simon, C., G. Brandenberger, and M. Follenius. 1987. Ultradian oscillations of plasma glucose, insulin, and C-peptide in man during continuous enteral nutrition. J. Clin. Endocrinol. & Metab. 64:669-674.
Sonnenberg, G. E., R. G. Hoffmann, C. P. Johnson, and A. H. Kissebah. 1992. Low- and high-frequency insulin secretion pulses in normal subjects and pancreas transplant recipients. Role of extrinsic innervation. J. Clin. Invest. 90:545-553.
Robbins, D. C., J. Jaspan, B. Vasquez, and E. Van Cauter. 1987. Biphasic patterns of peripheral insulin and glucose levels after lunch in normal subjects. Diabetes Care. 10:293-299.
Simon, C., M. Follenius, and G. Brandenberger. 1987. Postprandial oscillations of plasma glucose, insulin and C-peptide in man. Diabetologia. 30:769-773.
Polonsky, K. S., B. D. Given, and E. Van Cauter. 1988. 24-Hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J. Clin. Invest. 81:442-448.
Kraegen, E. W., J. D. Young, E. P. George, and L. Lazarus. 1972. Oscillations in blood glucose and insulin after oral glucose. Horm. Metab. Res. 4:409-413.
O'Meara, N. M., J. Sturis, E. Van Cauter, and K. S. Polonsky. 1993. Lack of control by glucose of ultradian insulin secretory oscillations in impaired glucose tolerance and in non-insulin-dependent diabetes mellitus. J. Clin. Invest. 92:262-271.
Sonnenberg, G. E., R. G. Hoffman, R. A. Mueller, and A. H. Kissebah. 1994. Splanchnic insulin dynamics and secretion pulsatilities in abdominal obesity. Diabetes. 43:468-477.
Polonsky, K. S., B. D. Given, L. J. Hirsch, H. Tillil, E. T. Shapiro, C. Beebe, B. H. Frank, J. A. Galloway, and E. Van Cauter. 1988. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 318:1231-1239.
Simon, C., G. Brandenberger, M. Follenius, and J. L. Schlienger. 1991. Alteration in the temporal organisation of insulin secretion in type 2 (non-insulin-dependent) diabetic patients under continuous enteral nutrition. Diabetologia. 34:435-440.
Matthews, D. R., B. A. Naylor, R. G. Jones, G. M. Ward, and R. C. Turner. 1983. Pulsatile insulin has greater hypoglycemic effect than continuous delivery. Diabetes. 32:617-621.
Verdin, E., M. Castillo, A. S. Luyckx, and P. J. Lefebvre. 1984. Similar metabolic effects of pulsatile versus continuous human insulin delivery during euglycemic, hyperinsulinemic glucose clamp in normal man. Diabetes. 33:1169-1174.
Bratusch-Marrain, P. R., M. Komjati, and W. K. Waldhausl. 1986. Efficacy of pulsatile versus continuous insulin administration on hepatic glucose production and glucose utilization in type I diabetic humans. Diabetes. 35:922-926.
Paolisso, G., A. J. Scheen, D. Giugliano, S. Sgambato, A. Albert, M. Varricchio, F. D'Onofrio, and P. J. Lefebvre. 1991. Pulsatile insulin delivery has greater metabolic effects than continuous hormone administration in man: importance of pulse frequency. J. Clin. Endocrinol. & Metab. 72:607-615.
Van Cauter, E., J. D. Blackman, D. Roland, J. P. Spire, S. Refetoff, and K. S. Polonsky. 1991. Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep. J. Clin. Invest. 88:934-942.
Morgan, C. R., and A. Lazarow. 1963. Immunoassay of insulin: two antibody system: plasma insulin levels of normal, subdiabetic and diabetic rats. Diabetes. 12:115-126.
Faber, O. K., C. Binder, J. Markussen, L. G. Heding, V. K. Naithani, H. Kuzuya, P. Blix, D. L. Horwitz, and A. H. Rubenstein. 1978. Characterization of seven C-peptide antisera. Diabetes. 27(Suppl. 1):170-177.
Soybel, D., J. Jaspan, K. Polonsky, I. Goldberg, E. Rayfield, and H. Tager. 1983. Differential immunoreactivity of plasma glucagon antibodies. J. Clin. Endocrinol. & Metab. 56:612-618.
Polonsky, K. S., J. Licinio-Paixao, B. D. Given, W. Pugh, P. Rue, J. Galloway, T. Karrison, and B. Frank. 1986. Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. J. Clin. Invest. 77:98-105.
Van Cauter, E., F. Mestrez, J. Sturis, and K. S. Polonsky. 1992. Estimation of insulin secretion rates from C-peptide levels: comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes. 41:368-377.
Rechtschaffen, A., and A. Kales. 1968. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Government Printing Office, Washington, DC.
Cleveland, W. S. 1979. Robust locally weighted regression and smoothing scatterplots. J. Am. Stat. Assoc. 74:829-836.
Sturis, J., E. Van Cauter, J. D. Blackman, and K. S. Polonsky. 1991. Entrainment of pulsatile insulin secretion by oscillatory glucose infusion. J. Clin. Invest. 87:439-445.
Jenkins, G. M., and D. G. Watts. 1968. Spectral Analysis and Its Application. Holden Day, San Francisco. 525 pp.
Van Cauter, E. 1988. Estimating false-positive and false-negative errors in analyses of hormonal pulsatility. Am. J. Physiol. 254:E786-E794.
DeFronzo, R. A., and E. Ferrannini. 1987. Regulation of hepatic glucose metabolism in humans. Diabetes Metab. Rev. 3:415-459.
Marsh, B. D., D. J. Marsh, and R. N. Bergman. 1986. Oscillations enhance the efficiency and stability of glucose disposal. Am. J. Physiol. 250:E576-E582.
Lang, D. A., D. R. Matthews, J. Peto, and R. C. Turner. 1979. Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings. N. Engl. J. Med. 301:1023-1027.
Hansen, B. C., K. C. Jen, S. B. Pek, and R. A. Wolfe. 1982. Rapid oscillations in plasma insulin, glucagon, and glucose in obese and normal weight humans. J. Clin. Endocrinol. & Metab. 54:785-792.
Matthews, D. R., D. A. Lang, M. A. Burnett, and R. C. Turner. 1983. Control of pulsatile insulin secretion in man. Diabetologia. 24:231-237.
Jaspan, J. B., E. Lever, K. S. Polonsky, and E. Van Cauter. 1986. In vivo pulsatility of pancreatic islet peptides. Am. J. Physiol. 251:E215-E226.
Zhong, P., J. F. Cara, and H. S. Tager. 1993. Importance of receptor occupancy, concentration differences, and ligand exchange in the insulin-like growth factor I receptor system. Proc. Natl. Acad. Sci. USA. 90:11451-11455.
Lee, A., M. Ader, G. A. Bray, and R. N. Bergman. 1992. Diurnal variation in glucose tolerance: cyclic suppression of insulin action and insulin secretion in normal-weight, but not obese, subjects. Diabetes. 41:742-749.
Verrillo, A., A. De Teresa, C. Martino, G. Di Chiara, M. Pinto, L. Verrillo, F. Torello, and A. Gattoni. 1989. Differential roles of splanchnic and peripheral tissues in determining diurnal fluctuation of glucose tolerance. Am. J. Physiol. 257:E459-E465.
Bolli, G. B., and J. E. Gerich. 1984. The "dawn phenomenon" - a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus. N. Engl. J. Med. 310:746-750.
Bolli, G. B., P. De Feo, S. De Cosmo, G. Perriello, M. M. Ventura, F. Calcinaro, C. Lolli, P. Campbell, P. Brunetti, and J. E. Gerich. 1984. Demonstration of the dawn phenomenon in normal volunteers. Diabetes. 33:1150-1153.
Simon, C., M. Follenius, and G. Brandenberger. 1988. Absence of the dawn phenomenon in normal subjects. J. Clin. Endocrinol. & Metab. 67:203-205.
Campbell, P. J., G. B. Bolli, P. E. Cryer, and J. E. Gerich. 1985. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus: accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion. N. Engl. J. Med. 312:1473-1479.